Rekombinanter MHC Class II HLA-DP/DQ/DR Antikörper

Produktnummer ABIN6937399

Dieses Anti-MHC Class II HLA-DP/DQ/DR-Antikörper ist ein Kaninchen Monoklonal-Antikörper zur Detektion von MHC Class II HLA-DP/DQ/DR in FACS, IF, WB, Coat, ELISA und IHC (f). Geeignet für Human.

Kurzübersicht für Rekombinanter MHC Class II HLA-DP/DQ/DR Antikörper (ABIN6937399)

Target: MHC Class II HLA-DP/DQ/DR (HLA-DP/DQ/DR)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Monoklonal

Konjugat: Dieser MHC Class II HLA-DP/DQ/DR Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), Immunofluorescence (IF), Western Blotting (WB), Coating (Coat), ELISA, Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Klon: HLA-Pan-2967R

Produktdetails anti-MHC Class II HLA-DP/DQ/DR Antikörper

Spezifität: Reacts with a common epitope of human major histocompatibility (MHC) class II antigens, HLA-DP, -DQ and -DR. Human MHC class II antigens are transmembrane glycoproteins composed of an chain (36 kDa) and a ' chain (27 kDa). They are expressed primarily on antigen presenting cells such as B lymphocytes, monocytes, macrophages, and thymic epithelial cells and are also present on activated T lymphocytes. Human MHC class II genes are located in the HLA-D region that encodes at least six and ten ' chain genes. Three loci, DR, DQ and DP, encode the major expressed products of the human class II region. The human MHC class II molecules bind intracellularly processed peptides and present them to T-helper cells. They, therefore, have a critical role in the initiation of the immune response. It has been shown that some autoimmune diseases are associated with certain class II alleles.

Kreuzreaktivität (Details): Human.

Aufreinigung: 1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

Immunogen: Non-T, non-B human acute lymphoblastic leukemia REH6 cell line

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Known_Application: ELISA (For coating use Ab at 2-5 μg/mL, order Ab without BSA), Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), ,Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

Positive_Control: Ramos or Raji cells. Human tonsil or lymph node.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL

Buffer: Prepared in 10 mM PBS, WITHOUT BSA and Azide.

Konservierungsmittel: Azide free

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

Haltbarkeit: 24 months

Details zu MHC Class II HLA-DP/DQ/DR

Target: MHC Class II HLA-DP/DQ/DR (HLA-DP/DQ/DR)

Andere Bezeichnung: HLA-DP, HLA-DQ, HLA-DR

Hintergrund: HLA-DPB1, HLA-DQA1, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5,HLA-Pan (MHC II)
Cellular localisation: Cell Surface

Molekulargewicht: 33-35kDa

UniProt: P01908, P01909

Pathways: Human Leukocyte Antigen (HLA) in Adaptive Immune Response